Pfizer acquires King Pharmaceuticals - MarketLine Financial Deals

Pfizer acquires King Pharmaceuticals

Pfizer acquires King Pharmaceuticals - MarketLine Financial Deals
Pfizer acquires King Pharmaceuticals
Published Feb 28, 2011
5 pages — Published Feb 28, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Pfizer, Inc., a bio-pharmaceutical company, has completed the acquisition of all the outstanding common shares of King Pharmaceuticals, Inc., a diversified specialty pharmaceutical discovery and clinical development company

  
Source:
Document ID
MA34485_101013
Country
Ticker
PFE=US
Ticker
KG=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Pfizer acquires King Pharmaceuticals" Feb 28, 2011. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pfizer-acquires-King-Pharmaceuticals-2052-45080>
  
APA:
MarketLine Financial Deals. (2011). Pfizer acquires King Pharmaceuticals Feb 28, 2011. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Pfizer-acquires-King-Pharmaceuticals-2052-45080>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.